A Phase IIb, randomized, placebo-controlled study of the...

Diabetes, Obesity and Metabolism 2013 / 08 Vol. 15; Iss. 8

A Phase IIb, randomized, placebo-controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetes

Ferrannini, E., Seman, L., Seewaldt-Becker, E., Hantel, S., Pinnetti, S., Woerle, H. J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Language:
english
Journal:
Diabetes, Obesity and Metabolism
DOI:
10.1111/dom.12081
Date:
August, 2013
File:
PDF, 625 KB
english, 2013
Conversion to is in progress
Conversion to is failed